NCT05840341 2023-05-03
Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer
Fudan University
Phase 3 Unknown
Clinical Trials
25 trialsNCT04931394 2022-08-02
Organoid-Guided Adjuvant Chemotherapy for Pancreatic Cancer
Changhai Hospital
Phase 3 Unknown
NCT05178628 2022-03-29
imPaCT-PRO
Institute of Molecular Medicine and Biomedical Research
Phase 3 Unknown
NCT04897854 2021-05-24
TIMEPAN
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 3 Unknown
NCT03398291 2018-10-09
Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy
Fudan University
Phase 3 Unknown
NCT01077427 2017-11-17
HEAT
Klinikum der Universitaet Muenchen, Grosshadern
Phase 3 Unknown
NCT02871804 2016-08-18
COSMOS-DP
Wakayama Medical University
Phase 3 Unknown
NCT02117895 2016-08-11
Left Celiac Plexus Resection for Pancreatic Cancer at the Body and Tail
Fudan University
Phase 3 Unknown
NCT02506842 2016-08-11
Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection
Fudan University
Phase 3 Unknown
NCT02514928 2016-08-11
Resection of the Nerve Plexus on the Right Half of Celiac and SMA Associated With Extended Pancreatoduodenectomy in the Surgical Treatment for Adenocarcinoma of the Head of Pancreas
Fudan University
Phase 3 Unknown
NCT02510066 2015-07-28
Efficacy and Mechanisms of Acupuncture for Patients With Advanced Pancreatic Cancer Pain
Shanghai Cancer Hospital, China
Phase 3 Unknown
NCT02355119 2015-02-04
GIP-2
Azienda Ospedaliero, Universitaria Pisana
Phase 3 Unknown
NCT01586611 2014-10-02
Panc001
AHS Cancer Control Alberta
Phase 3 Unknown
NCT00005869 2013-12-04
Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00005870 2013-12-04
Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00005871 2013-12-04
Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01931449 2013-08-29
Evaluation of A New Digestive Reconstruction Procedure Following Pancreatoduodenectomy
Southwest Hospital, China
Phase 3 Unknown
NCT00440167 2012-07-09
Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine
Ludwig-Maximilians - University of Munich
Phase 3 Unknown
NCT00541021 2009-12-15
Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00813696 2008-12-23
GIP-1
Istituti Tumori Giovanni Paolo II
Phase 3 Unknown
NCT00809081 2008-12-16
Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy
Yonsei University
Phase 3 Unknown
NCT00075452 2008-07-24
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00268411 2008-05-27
Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00486460 2007-06-14
Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer
Tel-Aviv Sourasky Medical Center
Phase 3 Unknown
NCT00088660 2006-02-08
PANVACâ„¢-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
Therion Biologics Corporation
Phase 3 Unknown